Us Warehouse Ceftizoxime Sodium 68401-82-1/Cefadroxil Monohydrate 66592-87-8/Cefoxitin 35607-66-0/Cefazolin Sodium 27164-46-1/ Cefotaxime Sodium 64485-93-4

China Us Warehouse Ceftizoxime Sodium 68401-82-1/Cefadroxil Monohydrate 66592-87-8/Cefoxitin 35607-66-0/Cefazolin Sodium 27164-46-1/Cefotaxime Sodium 64485-93-4, Find details about China Cefotaxime Sodium, 64485-93-4 from Us Warehouse Ceftizoxime Sodium 68401-82-1/Cefadroxil Monohydrate 66592-87-8/Cefoxitin 35607-66-0/Cefazolin Sodium 27164-46-1/Cefotaxime Sodium 64485-93-4

Basic Info.

Model NO.

Cefotaxime sodium

C16h16n5nao7s2

477.45

CAS

64485-93-4

Appearance

White to Yellow Powder

Function

Biological and Pharmaceutical Intermediates

Shelf Life

2 Years

Test Method

HPLC UV

Storage

Cool Dry Place

Payment

Tt.Western Union .Credit Card.Moneygram

Delivery Time

Within 2 Days

Certificate

COA MSDS

Sample

Available

Trademark

Faithful

Transport Package

Aluminum Foil Bag Packaging

Specification

10g/bag; 100g/bag; 1kg/bag

Origin

China

Model NO.

Cefotaxime sodium

C16h16n5nao7s2

477.45

CAS

64485-93-4

Appearance

White to Yellow Powder

Function

Biological and Pharmaceutical Intermediates

Shelf Life

2 Years

Test Method

HPLC UV

Storage

Cool Dry Place

Payment

Tt.Western Union .Credit Card.Moneygram

Delivery Time

Within 2 Days

Certificate

COA MSDS

Sample

Available

Trademark

Faithful

Transport Package

Aluminum Foil Bag Packaging

Specification

10g/bag; 100g/bag; 1kg/bag

Origin

China

Product Desciption

US warehouse Ceftizoxime Sodium 68401-82-1/cefadroxil monohydrate 66592-87-8/Cefoxitin 35607-66-0/cefazolin sodium 27164-46-1/Cefotaxime sodium 64485-93-4

Introduction

Cefotaxime Sodium
CAS No. :64485 -93-4
Molecular formula: C16H16N5NaO7S2
Molecular Weight: 477.45
EINECS No. :264 -915-9
Mp :162-163 C
Refractive index: 61 °(C = 1, H2O)
Storage conditions :2-8 °C
Properties: white to yellowish white crystals; odorless or slight special smell

Function

Patients are susceptible to various infections, such as respiratory, facial, abdominal, biliary tract, meningitis, gonorrhea, urinary tract infections, septicemia

Application

The main clinical infection for susceptible strains of meningitis, pneumonia, skin and soft tissue infections, peritonitis, urinary tract infections, gonorrhea, liver and gallbladder infection, surgical trauma, sepsis, and genital infections. As a treatment for gonorrhea has been first-line drugs.

Specification

ITEMS	SPECIFICATION	RESULTS
Appearance	White to pale yellow Crystalline Powder	Passed
Identification	IR Spectrum HPLC RT Sodium	Passed Passed Passed
Clarity	Clear	Passed
Color of Solution	NMT 0.2(430mm,10% solution)	Passed
Specific optical rotation	+56°~+64°	+61°
PH	4.5~6.5	5.5
Loss on drying	≤3.0%	2.7%
Chromatographic purity Individual impurity Total impurity	≤1.0% ≤3.0%	≤0.6% ≤2.0%
Sterility	Sterile	Passed
Bacterial Endotoxins	NMT 0.20 USP EU/mg	Passed
Particulate matter	≥10um NMT 6000 ≥25 um NMT 600	Passed Passed
Assay(HPLC)	916-964μg/mg	940μg/mg